DMK Pharmaceuticals Corporation (DMKPQ)

DMK Pharmaceuticals Revenue

DMK Pharmaceuticals had revenue of $3.62M in the twelve months ending September 30, 2023, with 134.95% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $9.06K, a -99.40% decrease year-over-year. In the year 2022, DMK Pharmaceuticals had annual revenue of $4.76M with 115.34% growth.

• Revenue (ttm): $3.62M
• Revenue Growth: +134.95%
• P/S Ratio: 0.07
• Revenue / Employee: $329,063
• Employees: 11
• Market Cap: 254.36K USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	4.76M	2.55M	115.34%
Dec 31, 2021	2.21M	-567.91K	-20.45%
Dec 31, 2020	2.78M	-19.34M	-87.44%
Dec 31, 2019	22.11M	7.03M	46.58%
Dec 31, 2018	15.09M	2.01M	15.40%
Dec 31, 2017	13.07M	6.60M	101.94%
Dec 31, 2016	6.47M	-	-
Dec 31, 2015	0	-	-
Mar 31, 2014	0	-	-
Mar 31, 2013	0	-	-
Mar 31, 2012	0	-	-
Mar 31, 2011	0	-	-
Mar 31, 2010	290.29K	-369.25K	-55.99%
Mar 31, 2009	659.54K	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	0	-	-
Dec 31, 2006	2.66M	-9.54M	-78.19%
Dec 31, 2005	12.20M	10.17M	500.06%
Dec 31, 2004	2.03M	412.43K	25.45%
Dec 31, 2003	1.62M	218.87K	15.62%
Dec 31, 2002	1.40M	524.14K	59.73%
Dec 31, 2001	877.49K	-708.13K	-44.66%
Dec 31, 2000	1.59M	540.49K	51.71%
Dec 31, 1999	1.05M	213.42K	25.66%
Dec 31, 1998	831.72K	4.03K	0.49%
Dec 31, 1997	827.70K	180.04K	27.80%
Dec 31, 1996	647.66K	-352.34K	-35.23%
Jun 26, 1995	1.00M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.